These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27487530)

  • 1. [Modern look at pharmacotherapy of osteoarthritis accomplished with cardiovascular disease].
    Хайменова ГС; Бабанина МЮ; Волченко ГВ; Ткаченко МВ; Иваницкий ИВ; Ждан ВН
    Wiad Lek; 2016; 69(2 Pt 2):180-2. PubMed ID: 27487530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis].
    Хайменова ГС; Шилкина ЛН; Бабанина МЮ; Волченко ГВ; Ткаченко МВ; Ждан ВН
    Wiad Lek; 2016; 69(2 Pt 2):214-8. PubMed ID: 27487536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.
    Garg N; Krishan P; Syngle A
    Clin Rheumatol; 2015 Jun; 34(6):1065-71. PubMed ID: 25771851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensifying approach to the therapy of patients with constellation of the diseases: chronic obstructive pulmonary disease and osteoarthritis.
    Zhdan VN; Potyazhenko MМ; Khaymenova GS; Lyulka NN; Dubrovinskaya TV; Ivanitsky IV
    Wiad Lek; 2017; 70(3 pt 2):578-580. PubMed ID: 28713086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].
    Cosin Sales J; Fuentes Jiménez FJ; Mantilla Morató T; Ruiz E; Becerra V; Aceituno S; Ferrario MG; Lizán L; Gracia A
    Clin Investig Arterioscler; 2015; 27(5):228-38. PubMed ID: 25640158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study.
    Ikdahl E; Hisdal J; Rollefstad S; Olsen IC; Kvien TK; Pedersen TR; Semb AG
    Arthritis Res Ther; 2015 Oct; 17():279. PubMed ID: 26445924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Atherosclerosis; 2015 Aug; 241(2):450-4. PubMed ID: 26074319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Chogtu B; Kuriachan S; Magazine R; Shetty KR; Kamath A; George MM; Tripathy A; Kumar DM
    Indian J Pharmacol; 2016; 48(5):503-508. PubMed ID: 27721534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
    Meek C; Wierzbicki AS; Jewkes C; Twomey PJ; Crook MA; Jones A; Viljoen A
    Curr Med Res Opin; 2012 Mar; 28(3):371-8. PubMed ID: 22256801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention.
    Guo J; Zhang WZ; Zhao Q; Wo JS; Cai SL
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4457-4463. PubMed ID: 29077146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism.
    Duarte T; da Cruz IB; Barbisan F; Capelleto D; Moresco RN; Duarte MM
    Pharmacogenomics J; 2016 Nov; 16(6):501-506. PubMed ID: 26882122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin Decreases Mean Platelet Volume in Patients With Diabetes Mellitus.
    Akyüz A; Akkoyun DÇ; Değirmenci H; Oran M
    Angiology; 2016 Feb; 67(2):116-20. PubMed ID: 25943745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].
    Drapkina OM; Korneeva ON
    Kardiologiia; 2012; 52(8):89-92. PubMed ID: 23098406
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosuvastatin: Beyond the cholesterol-lowering effect.
    Cortese F; Gesualdo M; Cortese A; Carbonara S; Devito F; Zito A; Ricci G; Scicchitano P; Ciccone MM
    Pharmacol Res; 2016 May; 107():1-18. PubMed ID: 26930419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
    Kargiotis K; Athyros VG; Giouleme O; Katsiki N; Katsiki E; Anagnostis P; Boutari C; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jul; 21(25):7860-8. PubMed ID: 26167086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between statin use and incidence or progression of osteoarthritis: meta-analysis of observational studies.
    Wang J; Dong J; Yang J; Wang Y; Liu J
    Osteoarthritis Cartilage; 2020 Sep; 28(9):1170-1179. PubMed ID: 32360737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will statins be an effective anti-inflammatory intervention for prevention of cardiovascular disease in patients with HIV?
    Dubé MP
    J Infect Dis; 2014 Apr; 209(8):1149-50. PubMed ID: 24415787
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).
    Takayama T; Hiro T; Yoda S; Fukamachi D; Haruta H; Kogo T; Mineki T; Murata H; Oshima T; Hirayama A
    Heart Vessels; 2018 Jun; 33(6):590-594. PubMed ID: 29209775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.